Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee recommends approval of Novantrone for MS indication

Feb. 1, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Beclomethasone Clickhaler approved in France

Jan. 28, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

FDA approves new labeling for Hyalgan

Jan. 28, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Jan. 21, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...